THEME: CANCER

Co-Leads: Dr Quentin Campbell-Hewson & Dr Gail Halliday

ABOUT

CHILDREN’S CANCER

Despite improving survival rates, cancer is the leading cause of death in children and young people.

The most common types of childhood cancer are:

  • Acute leukaemias, diagnosed in 1 in 3 children with cancer
  • Cancers of the brain and spinal cord, diagnosed in 1 in 4 children with cancer

In the UK, around 1,800 children (aged 0 – 14 years) are diagnosed with cancer each year. This number includes non cancerous (benign) brain tumours.

Childhood cancer differs significantly from adulthood cancer.

TECHNOLOGY FOR CHILDREN’S CANCER

There is a growing need for technology to support children and young people with cancer, as well as to support health care professionals to provide optimal care.

Opportunities for medical technology in children’s cancer include:

  • Information exchange: Technology is needed to inform, guide, assist, and record the care of children and young people when receiving care away specialist centres.
  • Clinical monitoring: More efficient, convenient, and effective mechanisms for the monitoring children and young people’s vital signs, particularly when out of hospital
  • Care and protection of indwelling devices: More effective technologies for the securing, care, and protection of various indwelling devices, such as central catheters, nasogastric tubes, and gastrostomies.

THEME LEADS

Dr Quentin Campbell-Hewson

Dr Quentin Campbell-Hewson is a Consultant Paediatric Oncologist at the Great North Children’s Hospital in Newcastle. Quentin leads the Chemotherapy Services, the Solid Tumour service, and the Early Phase Trial service.

Quentin jointly established and leads the INCLuDE network encompassing the North of England, Scotland, and Northern Ireland, which identifies children who need novel therapies for cancer and facilitating trial delivery across this network. This network has become the template for the rest of the UK. Quentin is the Newcastle lead for the paediatric UK Paediatric Experimental Cancer Medicines Centre network and the European Innovative Therapies in Childhood cancer network. Quentin is also the NIHR Clinical Research Network lead for the North of England and North Cumbria.

Dr Gail Halliday

Dr Gail Halliday is a Consultant Paediatric Oncologist at the Great North Children’s Hospital in Newcastle.

2019 © Sheffield Children's NHS Foundation Trust